Kehoe Law Firm, P.C. is investigating whether certain officers and directors of First BanCorp. (“First BanCorp” or the “Company”) (NYSE: FBP) may have breached their fiduciary duties or otherwise failed to oversee and manage the Company appropriately. The investigation also concerns whether First BanCorp and its shareholders may have been harmed as a result.

If you currently own First BanCorp common stock, you may have rights in connection with this investigation.

What Is the Investigation About?

The investigation concerns allegations regarding banking services allegedly provided to Jeffrey Epstein, as well as First BanCorp’s oversight, compliance, and corporate governance.

On June 24, 2026, a plaintiff identified as Jane Doe filed a putative class action lawsuit against First BanCorp, alleging that the bank participated in and financially benefited from Jeffrey Epstein’s sex-trafficking operation.

Kehoe Law Firm is evaluating whether the Company’s officers and directors breached their fiduciary duties in connection with these matters and whether corporate-governance reforms or other relief may be appropriate for First BanCorp.

First BanCorp Shareholders May Have Legal Claims

Current First BanCorp shareholders who wish to learn more about the investigation and their potential legal rights are encouraged to contact the firm by completing Kehoe Law Firm’s Stockholder Information Request Form or contacting:

Michael Yarnoff, Esq.
(215) 792-6676, Ext. 804
[email protected]
[email protected]

There is no cost or obligation to speak with the firm. Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, and clients are not responsible for any fees or litigation expenses.

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Kehoe Law Firm, P.C. is investigating whether certain officers and directors of The Ensign Group, Inc. (“Ensign,” “Ensign Group,” or the “Company”) (NASDAQ: ENSG) may have breached their fiduciary duties or otherwise failed to oversee and manage the Company appropriately. The investigation also concerns whether Ensign Group and its shareholders may have been harmed as a result.

If you currently own Ensign common stock, you may have rights in connection with this investigation.

What Is the Investigation About?

The investigation concerns allegations regarding Ensign Group’s oversight of its skilled nursing facilities, regulatory compliance, and Medicare and Medicaid billing.

On June 11, 2026, short seller Muddy Waters Research published a report concerning Ensign Group. The report stated that Muddy Waters “. . . conclude[d] that Ensign engages in a systematic scheme at an estimated ~20% of Skilled Nursing Facilities (SNFs) to rent the licenses of Administrators who are not generally present at, nor actually managing, the facilities.”

Muddy Waters stated that it “. . . believe[d] this scheme, which could amount to fraud against states, Medicare, and Medicaid, is the pillar upon which Ensign’s acquisition strategy and margins is built.”

Additionally, the report stated that “[u]nder the False Claims Act, if these practices have been in place for one year at ~20% of facilities, [Muddy Waters] estimate[d] the violations carry theoretical sanctions in the billions of dollars.”

Kehoe Law Firm is evaluating whether the Company’s officers and directors breached their fiduciary duties in connection with these matters and whether corporate governance reforms or other relief may be appropriate for Ensign Group.

Ensign Group Shareholders May Have Legal Claims

Current Ensign Group shareholders who wish to learn more about the investigation and their potential legal rights are encouraged to contact the firm by completing Kehoe Law Firm’s Stockholder Information Request Form or contacting:

Michael Yarnoff, Esq.
(215) 792-6676, Ext. 804
[email protected]
[email protected]

There is no cost or obligation to speak with the firm. Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, and clients are not responsible for any fees or litigation expenses.

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Kehoe Law Firm, P.C. is investigating whether certain officers and directors of ADMA Biologics, Inc. (“ADMA,” “ADMA Biologics,” or the “Company”) (NASDAQ: ADMA) may have breached their fiduciary duties or otherwise failed to oversee and manage the Company appropriately. The investigation also concerns whether ADMA Biologics and its shareholders may have been harmed as a result.

If you currently own ADMA Biologics common stock, you may have rights in connection with this investigation.

What Is the Investigation About?

The investigation concerns allegations regarding ADMA Biologics’ reported growth, distribution practices, related-party disclosures, and corporate oversight.

In March 2026, short seller Culper Research published a report alleging, among other things, channel stuffing and an undisclosed related-party distributor. 

On May 6, 2026, ADMA Biologics reported that increased competition, aggressive pricing tactics, and higher inventory across the distribution network affected its first-quarter results, particularly BIVIGAM. 

Kehoe Law Firm is evaluating whether the Company’s officers and directors breached their fiduciary duties in connection with these matters and whether corporate-governance reforms or other relief may be appropriate for ADMA Biologics.

ADMA Biologics Shareholders May Have Legal Claims

Current ADMA Biologics shareholders who wish to learn more about the investigation and their potential legal rights are encouraged to contact the firm by completing Kehoe Law Firm’s Stockholder Information Request Form or contacting:

Michael Yarnoff, Esq.
(215) 792-6676, Ext. 804
[email protected]
[email protected]

There is no cost or obligation to speak with the firm. Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, and clients are not responsible for any fees or litigation expenses.

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Alibaba Group Holding Limited (“Alibaba” or the “Company”) (NYSE: BABA).

A securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Alibaba securities between June 26, 2025 and June 24, 2026, both dates inclusive (the “Class Period”). 

What Does the Alibaba Securities Class Action Allege?

According to the complaint, Alibaba and its CEO, Eddie Yongming Wu, made materially false and/or misleading statements or failed to disclose adverse facts concerning to the Company’s business which were allegedly known to the Alibaba Defendants or recklessly disregarded by them.

Specifically, the Alibaba Defendants allegedly made false and/or misleading statements and/or failed to disclose that:

1) Under the National Defense Authorization Act (“NDAA”), any entities directly or indirectly controlled by or affiliated with the Chinese Ministry of Industry and Information Technology (“MIIT”) were considered a Chinese military company;

2) Alibaba was directly or indirectly controlled by or affiliated with the MIIT;

3) The risk of Alibaba carrying out distillation attacks against third- party AI models was not a mere hypothetical or inadvertent, but ongoing; and

4) As a result, the Alibaba Defendants’ public statements about Alibaba’s business, operations, and prospects were materially false and/or misleading at all relevant times.

The complaint states that on June 8, 2026, the U.S. Department of Defense released an updated list of Chinese military companies that included Alibaba. According to the complaint, Alibaba’s share price declined $4.69, or approximately 3.9%, over the next two trading days.

The complaint also cites a June 24, 2026 Bloomberg report concerning Anthropic’s accusation that Alibaba had illicitly accessed its Claude artificial intelligence models. According to the complaint, Alibaba ADSs declined 2.7% on June 24 and another 4.7% on June 25, 2026.

Alibaba Investors May Have Legal Claims

Investors who acquired Alibaba securities during the Class Period and suffered an investment loss may have legal claims.

Affected Alibaba investors are encouraged to complete Kehoe Law Firm’s Stockholder Information Request Form or contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected], to discuss the class action, the lead plaintiff process or their potential legal rights.  

Investors have until October 5, 2026 to seek appointment as lead plaintiff. Investors are not required to seek appointment as lead plaintiff to remain potential members of the class. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. An investors ability to share in any potential future recovery is not dependent upon serving as a lead plaintiff. 

There is no cost or obligation to speak with the firm.

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]